James Treco

Entity
Individual
Business address
C/O Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., 10022 New York, NY
Signature Ownership
/s/ Jessica Morris, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
James Treco has filed 14 SEC EDGAR filings since 2/19/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Aug 20, 2025 Aug 20, 2025 001-36019
4 Open Document Open Filing TRECO - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP May 15, 2025 May 13, 2025 001-36019
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Feb 28, 2025 Feb 5, 2025 001-36019
4 Open Document Open Filing May 24, 2024 May 23, 2024 001-36019
4 Open Document Open Filing May 10, 2023 May 8, 2023 001-36019
4 Open Document Open Filing TRECO - CHANGES IN BENEFICIAL OWNERSHIP May 11, 2022 May 9, 2022 001-36019
4 Open Document Open Filing TRECO - CHANGES IN BENEFICIAL OWNERSHIP May 12, 2021 May 10, 2021 001-36019
4 Open Document Open Filing OWNERSHIP DOCUMENT Sep 1, 2020 Aug 31, 2020 001-36019
4 Open Document Open Filing OWNERSHIP DOCUMENT Aug 17, 2020 Aug 14, 2020 001-36019
4 Open Document Open Filing OWNERSHIP DOCUMENT May 6, 2020 May 4, 2020 001-36019
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 18, 2020 Mar 16, 2020 001-36019
4 Open Document Open Filing OWNERSHIP DOCUMENT May 8, 2019 May 6, 2019 001-36019
4 Open Document Open Filing OWNERSHIP DOCUMENT Feb 19, 2019 Feb 14, 2019 001-36019
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 19, 2019 Feb 14, 2019 001-36019